Common Contracts
4 similar Registration Rights Agreement contracts by Mateon Therapeutics Inc, Oncotelic Therapeutics, Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 13th, 2023 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of __________, 2023, by and among Oncotelic Therapeutics, Inc. (the “Company”), a Delaware corporation with offices at 29397 Agoura Road, Suite 107, Agoura Hills, California 91301, and the investors signatories hereto (each a “Purchaser” and collectively, the “Purchasers”). This Agreement is made pursuant to the Subscription Agreement and Investment Letter, dated as of the date hereof, executed by each of the Purchasers and the Company (the “Subscription Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 13th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 7, 2020, by and among Mateon Therapeutics, Inc. (the “Company”), a Delaware corporation with offices at 20397 Agoura Road, Suite 107, Agoura Hills, California 91301, and the investors signatories hereto (each a “Purchaser” and collectively, the “Purchasers”). This Agreement is made pursuant to the Subscription Agreement and Investment Letter, dated as of the date hereof, executed by each of the Purchasers and the Company (the “Subscription Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 29th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 23, 2020, by and among Mateon Therapeutics, Inc. (the “Company”), a Delaware corporation with offices at 20397 Agoura Road, Suite 107, Agoura Hills, California 91301, and the investors signatories hereto (each a “Purchaser” and collectively, the “Purchasers”). This Agreement is made pursuant to the Subscription Agreement and Investment Letter, dated as of the date hereof, executed by each of the Purchasers and the Company (the “Subscription Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 16th, 2018 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 12, 2018, by and among Mateon Therapeutics, Inc., a Delaware corporation with offices at 701 Gateway Boulevard, Suite 210, South San Francisco, California 94080, and the investors signatory hereto (each a “Purchaser” and collectively, the “Purchasers”). This Agreement is made pursuant to the Subscription Agreement and Investment Letter, dated as of the date hereof, executed by each of the Purchasers and the Company (the “Subscription Agreement”).
